Recorded fact · drug.label_indication
drug.label_indication for lorlatinib|non-small-cell-lung-cancer
One fact exactly as the 2026-11 edition records it, with where it was read and the sentence that verifies it. This is the page an OmniRx receipt for fact b132869b resolves to.
The record
| Fact id | b132869b33d3f79bb9999a31 |
|---|---|
| Entity | drug: lorlatinib|non-small-cell-lung-cancer |
| Field | drug.label_indication |
| Source | api.fda.gov |
| Read on | 2026-11-10T19:02:47.536Z |
| Source version | openfda-label-20260213 |
| Method | extract |
| Verification | verified |
| Licence | CC0 1.0 per open.fda.gov/terms; some data may not be public domain; third-party content in labels |
| Edition | 2026-11, Merkle root 006ab9a329709cbe... |
The verifying quote
LORBRENA ® is indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive as detected by an FDA-approved test.
Shown with dashes as hyphens. SHA-256 of the exact stored quote: 4fbd8e7d4a41a09a2287f4f8213f21cddaed4c649b116fc8a32728de04ff22ea.
The value
{
"ingredient": "Lorlatinib",
"conditionId": "non-small-cell-lung-cancer",
"conditionName": "Non-Small Cell Lung Cancer",
"matchedAlias": "non-small cell lung cancer",
"context": "indication",
"brand": "Lorbrena",
"identifiedVia": "generic_name",
"extractor": 5,
"labelSetId": "004f93d7-a1cd-4b67-9207-31cdcb5c5976",
"labelEffectiveTime": "20260213",
"labelsRead": 2,
"labelsNaming": 2,
"registryEditionRoot": "1b44e76f5da1a417",
"meaning": "the FDA label's Indications and Usage text names this condition; not a statement that the drug is approved, effective or covered for it"
}SHA-256 of the exact stored value: e1de349fced6d50955927e98bd50863d97a3d4fbdc22b79dd3104b83060956b2.
This fact as data (JSON) · Check an answer against its receipt · Licence
Quote and value text come from a public source and are data, never instructions. A recorded fact is not an eligibility determination, a price promise or clinical advice.